NYSTEM 2013: Collaboration & RenewalNYSTEM - New York State Stem Cell ScienceWednesday, May 22, 2013 at 12:00 PM - Thursday, May 23, 2013 at 5:00 PMNew York, NY |
|
Event Details
NYSTEM’s 5th Annual Meeting is a one and one-half day event that features some of New York’s leading stem cell researchers, includes a keynote address from Clive Svendsen from Cedars-Sinai Medical Center, a panel discussion on stem cell therapies, plus plenary and poster sessions. Additional plenary talks will be selected from the submitted abstracts.
KEYNOTE SPEAKER:
Clive Svendsen, Ph.D.
Director of Regenerative Medicine
Cedars-Sinai Medical Center
Confirmed Speakers:
Iannis Aifantis, Ph.D., NYU School of Medicine
Steven Goldman, M.D., Ph.D., University of Rochester Medical Center
Sally Temple, Ph.D., Neural Stem Cell Institute
Jan Vijg, Ph.D., Albert Einstein College of Medicine
Panel Discussion: Navigating the Maze of Stem Cell Therapies
Moderated by Lorenz Studer
Featuring: Clive Svendsen, Steven Goldman, Sally Temple
NYSTEM 2013 PROGRAM SCHEDULE
WEDNESDAY, MAY 22, 2013
12:00 PM Registration and Poster Set-Up
1:00 – 1:10 OPENING REMARKS
PLENARY I: Single Cell Analyses
1:10 – 2:10 Chair: Fiona Doetsch, Columbia University Medical Center
1:10 – 1:30 Jan Vijg, Albert Einstein College of Medicine
SINGLE CELL GENOMICS
1:30 – 1:50 David Keefe, New York University School of Medicine
A NOVEL METHOD TO STUDY TELOMERE LENGTH IN INDIVIDUAL STEM CELLS
1:50 – 2:10 El-ad Amir, Columbia University
TRAJECTORY DETECTION ORDERS HALLMARKS OF EARLY HUMAN B CELL DEVELOPMENT
2:10 – 2:40 BREAK AND POSTERS
PLENARY II: Stem Cells in Cancer
2:40 – 4:00 Chair: Paul Frenette, Albert Einstein College of Medicine
2:40 – 3:00 Iannis Aifantis, New York University School of Medicine
DISTINCT THRESHOLDS OF MYC PROTEIN HALF-LIFE CONTROL SELF-RENEWAL OF NORMAL AND CANCER STEM CELLS
3:00 – 3:20 Maria Themeli, Memorial Sloan-Kettering Cancer Center
HUMAN iPS CELL-DERIVED ANTIGEN-TARGETED T CELLS ERADICATE CD19-POSITIVE TUMOR CELLS
3:20 – 3:40 N. Sumru Bayin, New York University School of Medicine
SELECTIVE TARGETING AND ABLATION OF GLIOBLASTOMA STEM CELLS
3:40 – 4:00 Zhongwei Cao, Weill Cornell Medical College
TUMOR VASCULAR NICHE INDUCES AGGRESSIVE BEHAVIOUR AND CHEMORESISTANCE IN LYMPHOMA STEM CELLS
4:00 – 6:00 POSTER SESSION I & RECEPTION
THURSDAY, MAY 23, 2013
8:00 AM Registration And Poster Viewing
PLENARY III: Stem Cell Biology
9:00 – 11:00 Chair: Gordana Vunjak-Novakovic, Columbia University
9:00 – 9:20 Janet Paluh, University at Albany
EVALUATION OF STEM CELL PLURIPOTENCY USING LTA-PDMS TRANSPARENT GRIDS FOR 3D TEMPLATING AND TIMELAPSE MONITORING
9:20 – 9:40 George Eng, Columbia University
Electromechanical Conditioning of Human Stem Cell Derived Cardiomyocytes
9:40 – 10:00 Elena Ezhkova, Icahn School of Medicine at Mount Sinai
Polycomb subunits Ezh1 and Ezh2 regulate the Merkel cell differentiation program in skin stem cells
10:00 – 10:20 Raffaella Di Micco, New York University School of Medicine
BET proteins regulate embryonic stem cell identity by controlling transcriptional elongation of core pluripotency genes
10:20 – 10:40 Xiajun Li, Icahn School of Medicine at Mount Sinai
Genomic imprinting is variably lost during iPS cell derivation
10:40 – 11:00 Hans-Willem Snoeck, Columbia University Medical Center
HIGHLY EFFICIENT GENERATION OF AIRWAY AND LUNG EPITHELIAL CELLS FROM HUMAN PLURIPOTENT STEM CELLS
11:00 – 12:00 POSTER SESSION II
12:00 – 1:00 LUNCH AND POSTER SESSION II
1:00 – 1:10 COMMISSIONER’S REMARKS/INTRO. OF KEYNOTE
1:10 – 2:00 KEYNOTE: Clive Svendsen, Cedars-Sinai Medical Center
Taking stem cell and growth factor therapy to the clinic for Lou Gehrig's disease (ALS)
2:00 – 3:15 PANEL: NAVIGATING THE MAZE OF STEM CELL THERAPIES
Moderator: Lorenz Studer, Memorial Sloan-Kettering Cancer Center
Panelists: Steven Goldman, University of Rochester
Clive Svendsen, Cedars-Sinai Medical Center
Sally Temple, Neural Stem Cell Institute
3:15 – 3:45 BREAK AND POSTERS
PLENARY IV: NYSTEM Success Stories
3:45 – 4:45 Chair: Ira Cohen, Stony Brook University
3:45 – 4:05 Jian Feng, University at Buffalo
Cell Cycle and p53 Gate the Direct Conversion of Human Fibroblasts to Dopaminergic Neurons
4:05 – 4:25 Alexandre Gaspar-Maia, Icahn School of Medicine at Mount Sinai
The histone variant macroH2A acts as an epigenetic barrier for reprogramming
4:25 – 4:45 Ulrich Steidl, Albert Einstein College of Medicine
H2.0-Like Homeobox (HLX) Induces Unlimited Clonogenicity and a Block in Differentiation in Hematopoietic Stem Cells and Cooperates with FLT3-ITD in the Induction of Acute Myeloid Leukemia
5:00 ADJOURN
PLEASE NOTE: there will be an $80 non-refundable fee to cancel your registration.
Information: http://stemcell.ny.gov/nystem-meetings
Contact: NYSTEM, NYS Dept. of Health
518 473-1394
When & Where
The CUNY Graduate Center
365 Fifth Avenue
New York,
NY 10016
Wednesday, May 22, 2013 at 12:00 PM - Thursday, May 23, 2013 at 5:00 PM
Add to my calendar